Gyre Therapeutics Inc.

Lician Pro · $19.99/mo or $149/yr · AAPL vs MSFT

Gyre Therapeutics Inc. (GYRE) SEC filings

Gyre Therapeutics Inc. (GYRE) SEC filings — 10-K, 10-Q, 8-K, and Form 4 as cached from EDGAR. When an exhibit lands, this page shows the headline, the numbers, and why it matters.

Those exhibit numbers sit next to the income-statement cache: Latest reported GYRE revenue for 2025-12-31 was $116.6M. Net income was $9.9M. Revenue was up 10.2% from 2024-12-31 to 2025-12-31. GYRE currently screens at market cap $589.9M. The GYRE filings page is the source view; the stock page is the research view.

EDGAR remains the official archive. Lician caches 8-K exhibits so you can read what Gyre Therapeutics Inc. said without waiting on a live EDGAR scrape. Item 2.02 is the earnings exhibit — this page prefers EX-99.1 revenue, growth, EPS, and guidance over a form-type label. Form 4 insider prints stay on the same ticker timeline.

Earnings & events

All events

Event insights for GYRE — what management said, what changed, and why it matters.

Recent filings

These filings as JSON? API free 100/day

GYRE SEC filings FAQ

What is the latest GYRE SEC filing?

The latest cached Gyre Therapeutics Inc. (GYRE) filing on this page is 8-K · Sep 1, 2026. Filings: https://lician.com/sec/gyre

What is the latest GYRE filing accession number?

The latest cached Gyre Therapeutics Inc. (GYRE) accession number on this page is 0001140361-26-035189. Filing: https://lician.com/sec/gyre/0001140361-26-035189

Which item codes are on the latest GYRE filing?

Cached item codes on the latest Gyre Therapeutics Inc. (GYRE) 8-K are 7.01, 9.01.

How many GYRE SEC filings are listed on this page?

This page lists 5 cached Gyre Therapeutics Inc. (GYRE) SEC filings. Filings: https://lician.com/sec/gyre

What events are listed on the GYRE SEC page?

Cached event headlines on this Gyre Therapeutics Inc. (GYRE) SEC page: "GYRE earnings". Events: https://lician.com/sec/gyre

What are GYRE's latest revenue and net income?

Latest cached Gyre Therapeutics Inc. (GYRE) revenue for Dec 31, 2025 was $116.6M. Net income was $9.9M. Statements: https://lician.com/financials/gyre